annual EBIT:
-$241.60M-$64.69M(-36.57%)Summary
- As of today (September 17, 2025), NAMS annual earnings before interest & taxes is -$241.60 million, with the most recent change of -$64.69 million (-36.57%) on December 31, 2024.
- During the last 3 years, NAMS annual EBIT has fallen by -$200.22 million (-483.94%).
- NAMS annual EBIT is now -3534.22% below its all-time high of -$6.65 million, reached on December 1, 2020.
Performance
NAMS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$35.63M+$33.29M(+48.30%)Summary
- As of today (September 17, 2025), NAMS quarterly earnings before interest & taxes is -$35.63 million, with the most recent change of +$33.29 million (+48.30%) on June 30, 2025.
- Over the past year, NAMS quarterly EBIT has increased by +$16.58 million (+31.75%).
- NAMS quarterly EBIT is now -27805.25% below its all-time high of -$127.70 thousand, reached on December 1, 2020.
Performance
NAMS quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$172.15M+$16.58M(+8.78%)Summary
- As of today (September 17, 2025), NAMS TTM earnings before interest & taxes is -$172.15 million, with the most recent change of +$16.58 million (+8.78%) on June 30, 2025.
- Over the past year, NAMS TTM EBIT has dropped by -$64.99 million (-60.64%).
- NAMS TTM EBIT is now -134710.49% below its all-time high of -$127.70 thousand, reached on December 1, 2020.
Performance
NAMS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NAMS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.6% | +31.8% | -60.6% |
| 3 y3 years | -483.9% | -1690.0% | -5349.3% |
| 5 y5 years | -3534.2% | -10000.0% | -10000.0% |
NAMS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -981.1% | at low | -1453.7% | +48.3% | -3286.4% | +8.8% |
| 5 y | 5-year | -3534.2% | at low | <-9999.0% | +48.3% | <-9999.0% | +8.8% |
| alltime | all time | -3534.2% | at low | <-9999.0% | +48.3% | <-9999.0% | +8.8% |
NAMS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$35.63M(-48.3%) | -$172.15M(-8.8%) |
| Mar 2025 | - | -$68.92M(+59.4%) | -$188.73M(+8.0%) |
| Dec 2024 | -$241.60M(+36.6%) | -$43.23M(+77.4%) | -$174.76M(+32.9%) |
| Sep 2024 | - | -$24.36M(-53.3%) | -$131.53M(+22.7%) |
| Jun 2024 | - | -$52.22M(-5.0%) | -$107.17M(+95.0%) |
| Mar 2024 | - | -$54.95M(+42.3%) | -$54.95M(+28.1%) |
| Dec 2023 | -$176.91M(+691.6%) | - | - |
| Mar 2023 | - | -$38.63M | -$42.91M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$22.35M(-46.0%) | - | - |
| Sep 2022 | - | -$2.29M(+15.2%) | -$5.08M(+60.9%) |
| Jun 2022 | - | -$1.99M(+477.7%) | -$3.16M(+114.4%) |
| Mar 2022 | - | -$344.60K(-24.2%) | -$1.47M(+7.9%) |
| Dec 2021 | -$41.37M(+522.4%) | -$454.60K(+23.1%) | -$1.37M(+31.5%) |
| Sep 2021 | - | -$369.20K(+21.0%) | -$1.04M(+55.1%) |
| Jun 2021 | - | -$305.20K(+28.7%) | -$670.10K(+83.6%) |
| Mar 2021 | - | -$237.20K(+85.7%) | -$364.90K(+185.7%) |
| Dec 2020 | -$6.65M | -$127.70K | -$127.70K |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual earnings before interest & taxes?
- What is the all time high annual EBIT for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual EBIT year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly EBIT year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM EBIT year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual earnings before interest & taxes?
The current annual EBIT of NAMS is -$241.60M
What is the all time high annual EBIT for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual earnings before interest & taxes is -$6.65M
What is NewAmsterdam Pharma Company N.V. annual EBIT year-on-year change?
Over the past year, NAMS annual earnings before interest & taxes has changed by -$64.69M (-36.57%)
What is NewAmsterdam Pharma Company N.V. quarterly earnings before interest & taxes?
The current quarterly EBIT of NAMS is -$35.63M
What is the all time high quarterly EBIT for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly earnings before interest & taxes is -$127.70K
What is NewAmsterdam Pharma Company N.V. quarterly EBIT year-on-year change?
Over the past year, NAMS quarterly earnings before interest & taxes has changed by +$16.58M (+31.75%)
What is NewAmsterdam Pharma Company N.V. TTM earnings before interest & taxes?
The current TTM EBIT of NAMS is -$172.15M
What is the all time high TTM EBIT for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM earnings before interest & taxes is -$127.70K
What is NewAmsterdam Pharma Company N.V. TTM EBIT year-on-year change?
Over the past year, NAMS TTM earnings before interest & taxes has changed by -$64.99M (-60.64%)